フィブリンシーラント市場 - 世界の産業規模、シェア、動向、機会、予測：タイプ別、エンドユーザー別、地域別、競合、2020年～2030年

フィブリンシーラントの世界市場規模は2024年に13億2,000万米ドル、2030年には18億6,000万米ドルに達し、CAGRで6.09%の成長が予測されています。

フィブリンシーラント市場は現代の外科手術と創傷管理に不可欠な要素となり、医療技術の進化する状況において極めて重要な役割を果たしています。フィブリンシーラントは一般にフィブリン接着剤と呼ばれ、手術中や手術後の血液凝固を促進し、創傷を密封するために使用される止血剤です。人口の高齢化、慢性疾患の増加、外傷率の上昇などを背景に、世界的に外科手術が増加しており、フィブリンシーラントの需要は増加の一途をたどっています。この市場の主な促進要因は、低侵襲手術へのシフトであり、精密で迅速な作用と効果的な創傷閉鎖を提供するツールが必要とされています。フィブリンシーラントは、適用が容易で生体適合性が高く、術後の合併症を大幅に軽減できるため、このような手術で高く評価されています。外科医は、計画的な手術だけでなく、外傷や事故などの緊急手術においても、迅速な創傷閉鎖と出血抑制が不可欠となるフィブリンシーラントを使用しています。

しかし、フィブリンシーラントはその臨床的有用性が広く知られているにもかかわらず、一定の限界に直面しています。特に発展途上国や予算が限られている医療システムでは、高品質なシーラントの高価格が採用の障壁となる可能性があります。多くのシーラントはヒト血漿に由来するため、疾患伝播のリスクは最小限でも顕著であり、長期的な安全性に対する懸念があります。

市場促進要因

フィブリンシーラントのマイクロサージャリーおよびインプラント部位のフラップ閉鎖における新たな用途が、フィブリンシーラント市場成長の主な要因です。

主な市場課題

フィブリンシーラントの高コスト

主要市場動向

政府の資金援助とヘルスケアの質の向上

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のフィブリンシーラント市場に与える影響

第5章 世界のフィブリンシーラント市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェア・予測
  • タイプ別（液体、パッチ）
  • エンドユーザー別（外来手術センター、病院、専門クリニック）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 アジア太平洋地域のフィブリンシーラント市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州のフィブリンシーラント市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米のフィブリンシーラント市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米のフィブリンシーラント市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのフィブリンシーラント市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート
  • トルコ
  • エジプト

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のフィブリンシーラント市場：SWOT分析

第14章 価格分析

第15章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替資源の脅威

第16章 PESTEL分析

第17章 競合情勢

• Johnson and Johnson
• Baxter International Inc.
• Nordson Corporation（Nordson Medical）
• Corza Health Inc
• Becton Dickinson and Company
• CSL Behring LLC
• Grifols SA
• Shanghai RAAS Blood Products Co., Ltd.
• Vivostat A/S
• Hemarus Therapeutics Ltd.

第18章 戦略的提言

第19章 調査会社について・免責事項

Global Fibrin Sealant Market was valued at USD 1.32 Billion in 2024 and is expected to reach USD 1.86 Billion by 2030 with a CAGR of 6.09%. The fibrin sealant market has become an essential component of modern surgical procedures and wound management, playing a pivotal role in the evolving landscape of medical technology. Fibrin sealants, commonly referred to as fibrin glues, are hemostatic agents used to promote blood clotting and seal wounds during and after surgeries. With the global increase in surgical procedures, fueled by an aging population, rising cases of chronic diseases, and higher rates of trauma-the demand for fibrin sealants continues to grow. The key drivers of this market is the shift toward minimally invasive surgeries, which require tools that offer precision, rapid action, and effective wound closure. Fibrin sealants are highly valued in such procedures due to their ease of application, biocompatibility, and ability to significantly reduce post-operative complications. Surgeons rely on them not only in planned operations but also in emergency settings like trauma or accident cases, where quick wound sealing and bleeding control are critical.

However, despite their widespread clinical benefits, fibrin sealants face certain limitations. The high cost of quality sealants can be a barrier to adoption, especially in developing countries or healthcare systems with limited budgets. Since many sealants are derived from human plasma, there is a minimal yet notable risk of disease transmission, prompting concerns about long-term safety.

Key Market Drivers

Emerging Applications of Fibrin Sealant in Microsurgery and Implant Site Flap Closure is Major Factor for Fibrin Sealant Market Growth

The global fibrin sealant market is experiencing substantial growth, primarily driven by the emerging applications of fibrin sealant in microsurgery and implant site flap closure. Fibrin sealant, also known as tissue glue or surgical glue, is a biocompatible adhesive derived from human plasma proteins. It has been widely used in various surgical procedures for hemostasis and tissue sealing. Microsurgery is a highly specialized field that involves intricate procedures on very small structures, often using high-powered microscopes. Fibrin sealant has found emerging applications in microsurgery due to its ability to provide precise and controlled tissue adhesion.

In microsurgical applications, the use of fibrin sealant offers several advantages, including reduced operative time, minimal tissue trauma, and improved postoperative recovery. It allows surgeons to achieve hemostasis and close tissues with high precision. Fibrin sealant is increasingly utilized in implant dentistry for site flap closure during dental implant procedures. It plays a crucial role in securing flaps over implant sites, ensuring proper healing and osseointegration. The success of microsurgical and implant procedures heavily relies on the choice of adhesive. Surgeons demand reliable, biocompatible adhesives that can securely close tissues and promote effective healing without causing adverse reactions.

Fibrin sealant is known for its versatility. It can be used in various surgical specialties, including neurosurgery, ophthalmology, plastic surgery, and more, making it a valuable tool in the medical field. In microsurgery and implant site flap closure, precision and safety are paramount. Fibrin sealant provides the controlled and localized tissue adhesion required for successful outcomes while minimizing the risk of complications. Ongoing research and development efforts in the field of fibrin sealant have led to advanced formulations that offer improved adhesion strength, hemostatic properties, and biocompatibility. These advancements contribute to its growing adoption in microsurgery and implant dentistry. The increasing demand for precise and effective tissue adhesives in microsurgery and implant procedures is driving the need for specialized fibrin sealant products. Surgeons and healthcare professionals seek advanced solutions to enhance surgical outcomes.

The global fibrin sealant market is experiencing robust growth, primarily driven by the emerging applications of fibrin sealant in microsurgery and implant site flap closure. Fibrin sealant has become an essential tool in achieving secure tissue adhesion and promoting healing in delicate surgical procedures. As the awareness of its benefits in microsurgery and implant dentistry continues to grow, the market for fibrin sealant is expected to thrive. Manufacturers and suppliers in this market must remain at the forefront of technology and innovation to meet the evolving demands of surgeons and healthcare professionals, ensuring continued growth and improved surgical outcomes worldwide.

Key Market Challenges

High Cost of Fibrin Sealants

The high cost of fibrin sealants represents a substantial obstacle to the growth of the global Fibrin Sealant market. Fibrin sealants are biologically derived adhesives used in surgical procedures to facilitate hemostasis, tissue sealing, and wound closure. Their effectiveness and safety have made them invaluable in various surgical applications, including cardiovascular, orthopedic, and general surgery. However, the production and processing of fibrin sealants involves complex biotechnological processes and stringent quality control, resulting in elevated production costs.

The high cost of fibrin sealants can strain healthcare budgets, deter some healthcare facilities from adopting these products, and limit market growth potential. Additionally, affordability concerns can lead to a preference for alternative hemostatic and tissue sealing solutions, further hampering market expansion.

To address this challenge and stimulate growth in the Fibrin Sealant market, manufacturers must explore strategies to optimize production processes, improve cost-efficiency, and collaborate with healthcare providers to showcase the long-term benefits and cost-effectiveness of fibrin sealant use. By making these vital surgical aids more accessible, the market can continue to advance in the field of medical procedures and surgical interventions.

Key Market Trends

Government Funding and Improvement in the Quality of Healthcare

Advancements in bonding technologies are a fundamental trend driving the growth of the global Fibrin Sealant market. As industries continue to evolve, there is a growing demand for Fibrin Sealant that offer improved bonding capabilities, versatility, and efficiency. These advancements are not only transforming traditional bonding processes but also expanding the applications of Fibrin Sealant across various sectors.

The development of innovative bonding technologies includes the formulation of adhesive products with enhanced chemical compositions, allowing them to bond a wider range of plastic substrates effectively. Additionally, improvements in curing mechanisms, such as UV curing and cyanoacrylate technology, have accelerated bonding speeds and enhanced the overall performance of Fibrin Sealant.

These advancements are particularly crucial in industries like automotive, electronics, and medical devices, where plastic components play a significant role. As manufacturers seek reliable, high-performance bonding solutions to improve product quality and assembly efficiency, the global Fibrin Sealant market is poised for substantial growth. Companies that invest in cutting-edge bonding technologies and adapt to evolving industry demands are well-positioned to capitalize on this transformative trend.

Key Market Players

• Johnson and Johnson
• Baxter International Inc.
• Nordson Corporation (Nordson Medical)
• Corza Health Inc
• Becton Dickinson and Company
• CSL Behring LLC
• Grifols SA
• Shanghai RAAS Blood Products Co., Ltd.
• Vivostat A/S
• Hemarus Therapeutics Ltd

Report Scope:

In this report, the Global Fibrin Sealant Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fibrin Sealant Market, By Type:

• Liquid Form
• Patch

Fibrin Sealant Market, By End User:

• Ambulatory Surgical Centers
• Hospitals
• Specialty Clinics

Fibrin Sealant Market, By Region:

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkiye
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fibrin Sealant Market.

Available Customizations:

Global Fibrin Sealant market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Fibrin Sealant Market

5. Global Fibrin Sealant Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value & Volume
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Liquid Form, Patch)
  • 5.2.2. By End User (Ambulatory Surgical Centers, Hospitals, Specialty Clinics)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Fibrin Sealant Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value & Volume
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Fibrin Sealant Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value & Volume
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. India Fibrin Sealant Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value & Volume
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Australia Fibrin Sealant Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value & Volume
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User
  • 6.3.4. Japan Fibrin Sealant Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value & Volume
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By End User
  • 6.3.5. South Korea Fibrin Sealant Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value & Volume
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By End User

7. Europe Fibrin Sealant Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value & Volume
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Fibrin Sealant Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value & Volume
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Germany Fibrin Sealant Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value & Volume
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Spain Fibrin Sealant Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value & Volume
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Fibrin Sealant Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value & Volume
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. United Kingdom Fibrin Sealant Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value & Volume
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. North America Fibrin Sealant Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value & Volume
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Fibrin Sealant Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value & Volume
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. Mexico Fibrin Sealant Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value & Volume
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Canada Fibrin Sealant Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value & Volume
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User

9. South America Fibrin Sealant Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value & Volume
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Fibrin Sealant Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value & Volume
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Fibrin Sealant Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value & Volume
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Fibrin Sealant Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value & Volume
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Fibrin Sealant Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1.By Value & Volume
• 10.2. Market Share & Forecast
  • 10.2.1.By Type
  • 10.2.2.By End User
  • 10.2.3.By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Fibrin Sealant Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value & Volume
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Fibrin Sealant Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value & Volume
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Fibrin Sealant Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value & Volume
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User
  • 10.3.4. Kuwait Fibrin Sealant Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value & Volume
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Type
      • 10.3.4.2.2. By End User
  • 10.3.5. Turkiye Fibrin Sealant Market Outlook
    • 10.3.5.1. Market Size & Forecast
      • 10.3.5.1.1. By Value & Volume
    • 10.3.5.2. Market Share & Forecast
      • 10.3.5.2.1. By Type
      • 10.3.5.2.2. By End User
  • 10.3.6. Egypt Fibrin Sealant Market Outlook
    • 10.3.6.1. Market Size & Forecast
      • 10.3.6.1.1. By Value & Volume
    • 10.3.6.2. Market Share & Forecast
      • 10.3.6.2.1. By Type
      • 10.3.6.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends and Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Fibrin Sealant Market: SWOT Analysis

14. Pricing Analysis

15. Porter's Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Sources

16. PESTLE Analysis

17. Competitive Landscape

• 17.1. Johnson and Johnson
  • 17.1.1.Business Overview
  • 17.1.2.Company Snapshot
  • 17.1.3.Products & Services
  • 17.1.4.Financials (In case of listed companies)
  • 17.1.5.Recent Developments
  • 17.1.6.SWOT Analysis
• 17.2. Baxter International Inc.
• 17.3. Nordson Corporation (Nordson Medical)
• 17.4. Corza Health Inc
• 17.5. Becton Dickinson and Company
• 17.6. CSL Behring LLC
• 17.7. Grifols SA
• 17.8. Shanghai RAAS Blood Products Co., Ltd.
• 17.9. Vivostat A/S
• 17.10. Hemarus Therapeutics Ltd.

18. Strategic Recommendations

19. About us & Disclaimer